POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,010 | -11.8% | 16,811 | -34.8% | 0.00% | – |
| Q2 2023 | $45,375 | +4025.0% | 25,781 | +7121.6% | 0.00% | – |
| Q1 2023 | $1,100 | -98.6% | 357 | -97.5% | 0.00% | – |
| Q4 2022 | $76,060 | +52.1% | 14,351 | +0.1% | 0.00% | – |
| Q3 2022 | $50,000 | +35.1% | 14,330 | +0.9% | 0.00% | – |
| Q2 2022 | $37,000 | -42.2% | 14,201 | +0.5% | 0.00% | – |
| Q1 2022 | $64,000 | -79.7% | 14,126 | -69.5% | 0.00% | – |
| Q4 2021 | $315,000 | +31400.0% | 46,298 | +34974.2% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -97.8% | 132 | -97.2% | 0.00% | – |
| Q1 2021 | $46,000 | +187.5% | 4,766 | +229.1% | 0.00% | – |
| Q4 2020 | $16,000 | -56.8% | 1,448 | -65.2% | 0.00% | – |
| Q3 2020 | $37,000 | – | 4,166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |